Cargando…
What Do Influenza and COVID-19 Represent for Patients With Inflammatory Bowel Disease?
BACKGROUND: Inflammatory bowel diseases (IBD) are a group of immune and inflammatory diseases; and patients seem to be more vulnerable to influenza and coronavirus disease 2019 (COVID-19). These conditions are characterized by the augmented release of inflammatory cytokines that have been suggested...
Autores principales: | Barbalho, Sandra Maria, Matias, Julia Novaes, Flato, Uri Adrian Prync, Pilon, Joao Paulo Galletti, Bitelli, Piero, Pagani Junior, Marcos Alberto, de Carvalho, Antonelly Cassio Alves, Haber, Jesselina Francisco dos Santos, Reis, Carlos Henrique Bertoni, Goulart, Ricardo de Alvares |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935616/ https://www.ncbi.nlm.nih.gov/pubmed/33737994 http://dx.doi.org/10.14740/gr1358 |
Ejemplares similares
-
Cannabis and Canabidinoids on the Inflammatory Bowel Diseases: Going Beyond Misuse
por: de Carvalho, Antonelly Cassio Alves, et al.
Publicado: (2020) -
Omega Fatty Acids and Inflammatory Bowel Diseases: An Overview
por: Marton, Ledyane Taynara, et al.
Publicado: (2019) -
Organokines in Rheumatoid Arthritis: A Critical Review
por: Laurindo, Lucas Fornari, et al.
Publicado: (2022) -
Non-Alcoholic Steatohepatitis (NASH) and Organokines: What Is Now and What Will Be in the Future
por: dos Santos, João Paulo Margiotti, et al.
Publicado: (2022) -
Phytochemicals and Regulation of NF-kB in Inflammatory Bowel Diseases: An Overview of In Vitro and In Vivo Effects
por: Laurindo, Lucas Fornari, et al.
Publicado: (2023)